~~<i id='38BAD5D98A'><strike id='38BAD5D98A'><tt id='38BAD5D98A'><pre id='38BAD5D98A'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：focus 2025-10-06 13:24:23 Page View：78451

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

2:59PoliceofficersworkatthesceneasinvestigationsareongoingthedayafteramassshootingintheKingsessingse

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

FILE-InthisimagetakenfromvideoreleasedonJan.27,2023,bythecityofMemphis,Tenn.,TyreNicholsleansagainst